Celexa vs. Escitalopram

See how Celexa and Escitalopram compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Both Celexa and escitalopram are SSRIs for major depressive disorder, but escitalopram also has FDA approval for generalized anxiety disorder and for adolescents ages 12 to 17.

  • Celexa's label carries a warning about dose-dependent QT prolongation and caps dosing at 40 mg, while escitalopram has no such cardiac warning and tops out at 20 mg.

  • Escitalopram tends to show somewhat lower rates of nausea, dry mouth, and somnolence in trials, and its typical list price is generally lower than Celexa's.

Celexa vs. Escitalopram Drug Summary

Celexa

Celexa (citalopram) is a selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder in adults. It's taken once daily as a tablet or oral solution, usually starting at 20 mg for one week before moving to a 40 mg maintenance dose. It's also commonly prescribed off-label for anxiety disorders and OCD.

Escitalopram

Escitalopram is an SSRI approved for major depressive disorder in adults and adolescents 12 to 17, as well as generalized anxiety disorder in adults. It's taken once daily as a tablet or oral solution, usually starting at 10 mg for one week before moving to a 20 mg maintenance dose.

Celexa vs. Escitalopram Side Effects

Celexa

Most common
Nausea (up to 21%)
Somnolence (up to 18%)
Insomnia (up to 15%)
Dry mouth (up to 20%)

Escitalopram

Most common
Nausea (up to 15%)
Somnolence (up to 7%)
Insomnia (up to 9%)
Ejaculation disorder (up to 9%)

Celexa vs. Escitalopram Dosage

Celexa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg once daily Week 1
Maximum dose 40 mg once daily Week 2 onward
Dose changes 1 increase Every week

Escitalopram

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Week 1
Maximum dose 20 mg once daily Week 2 onward
Dose changes 1 increase Every week

Celexa vs. Escitalopram Indications

Celexa

Celexa is FDA-approved only for major depressive disorder in adults, but clinicians commonly prescribe it off-label for several anxiety-related conditions. Its long history on the market has generated substantial real-world experience supporting these off-label uses.

  • Major depressive disorder (MDD) in adults

  • Generalized anxiety disorder (off-label)

  • Panic disorder (off-label)

Escitalopram

Escitalopram carries FDA approval for major depressive disorder in both adults and adolescents ages 12 to 17, plus generalized anxiety disorder in adults. This broader approved label means fewer conditions require off-label prescribing compared with citalopram.

  • Major depressive disorder (MDD) in adults

  • Major depressive disorder in adolescents 12-17

  • Generalized anxiety disorder (GAD) in adults

Celexa vs. Escitalopram Pros and Cons

Celexa

Celexa has decades of clinical use and a well-documented safety profile, but its labeling carries a dose-dependent QT prolongation warning that limits dosing above 40 mg. It's not FDA-approved for anxiety disorders, though it's widely used off-label for that purpose, and it isn't approved for any pediatric age group.

Pros

  • Higher maximum approved dose (40 mg) allows more room to escalate if 20 mg isn't enough

  • Long-established safety and tolerability record since 1998 as one of the most prescribed SSRIs

  • Extensive real-world off-label use for generalized anxiety disorder, panic disorder, and OCD

Cons

  • Carries a warning for dose-dependent QT prolongation; doses above 40 mg/day aren't recommended

  • Not FDA-approved for anxiety disorders; GAD, panic disorder, and OCD use is off-label only

  • Not approved for any pediatric use, unlike escitalopram's approval for adolescents 12-17

  • Higher reported rates of nausea (21%), dry mouth (20%), and somnolence (18%) in trials

Escitalopram

Escitalopram, the active enantiomer of citalopram, has a broader FDA-approved label covering GAD in adults and MDD in adolescents. Its trial data show somewhat lower rates of nausea, dry mouth, and somnolence, though its maximum approved dose is lower at 20 mg.

Pros

  • FDA-approved for generalized anxiety disorder, not just used off-label like citalopram

  • Approved for adolescents aged 12-17 with major depressive disorder

  • Lower rates of common side effects in trials, including nausea (up to 15%) and insomnia (up to 9%)

Cons

  • Maximum approved dose is 20 mg, offering less room to escalate than citalopram's 40 mg ceiling

  • Not approved for panic disorder or OCD, with less off-label track record for these than citalopram

  • Slightly higher reported rate of sexual side effects, including ejaculation disorder (up to 9%)

  • Fewer decades on the market means somewhat less accumulated real-world data than citalopram

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.